| Vaccination status |
Eligible group |
Total |
| Age group |
18-44 years |
45-59 years |
60+ years |
|
| Study participants eligible for COVID-19 vaccination |
| No |
0 |
0 |
0 |
9.9% *
(1264) |
| Yes |
52.4%
(6716) |
19.4%
(2491) |
18.3%
(2341) |
90.1%
(11548) |
| Percentage of study participants who have received first dose (partially vaccinated) |
| No |
6.1%
(781) |
1.3%
(163) |
1.8%
(230) |
19.0%
(2438) |
| Yes |
46.3%
(5935) |
18.1%
(2328) |
16.5%
(2111) |
81.0%
(10374) |
| Total |
52.4%
(6716) |
19.4%
(2491) |
18.3%
(2341) |
100%
(12812) |
| Percentage of study participants who have received a second dose (fully vaccinated) |
| No |
24.1%
3083 |
4.5%
580 |
3.8%
(481) |
42.2%
(5408) |
| Yes |
28.3%
(3633) |
14.9%)
(1911) |
14.5%
(1860) |
57.8%
(7404) |
| Total |
52.4%
(6716) |
19.4%
(2491) |
18.3%
(2341) |
100%
(12812) |